Executive Director, Global Data and Analytics
Revolution Medicines
Summary
Reporting to the Vice President, Global Analytics & Insights, the Executive Director, Global Data & Analytics will build and lead capabilities in disease and customer analytics, data governance, commercial data systems, portfolio analytics and reporting. The role will develop the team, tools and data foundations needed to support decisions from early development through commercialization across an expanding portfolio and geographic footprint.
Job description
Responsibilities
- Set the global Data & Analytics strategy and capability roadmap with regional partners and Information Systems.
- Identify unmet needs, prioritize investments and sequence development around business value, readiness and opportunities to create scale across disease areas and regions.
- Balance new capability development with capacity for ongoing delivery, maintenance and user support.
- Build, coach and develop the Data & Analytics team and its leaders.
- Establish clear accountabilities, align resources with priorities and manage functional budgets, vendors and delivery.
- Coordinate with regional analytics leaders to agree where global leads, jointly develops, supports or facilitates information sharing.
- Develop shared analytical capabilities, reusable methods and tools where common needs justify global investment.
- Lead shared disease analytics capabilities and agreed analyses to understand patient populations, diagnosis and biomarker testing, treatment pathways, utilization and gaps in care.
- Advance shared customer analytics methods, tools and specialist support to understand healthcare professional and account needs, behaviors and engagement.
- Provide analytical foundations, reusable methods and agreed analyses for portfolio assessments with Forecasting and Disease Area Insights.
- Lead the business approach to global performance reporting and dashboards with regional partners.
- Lead the commercial business contribution to data governance in partnership with Information Systems, regional teams and relevant enterprise functions.
- Define and coordinate business requirements and priorities for shared commercial data systems, integration and analytical platforms with regional teams.
- Coordinate data sourcing and vendor strategy across regions and functions with Procurement and relevant data owners.
- Evaluate and introduce advanced analytics, automation and AI where they address material business needs.
- Partner with business leaders to translate questions into analytical plans and actionable recommendations.
- Establish quality assurance, documentation and training that strengthen analytical rigor, user adoption and informed interpretation of results.
- Travel domestically and internationally as needed, typically up to 25–30%.
Required Skills, Experience and Education
- Bachelor’s degree in a quantitative, scientific, technology or business discipline and 15+ years of relevant biotechnology, pharmaceutical or consulting experience.
- Experience leading teams and managers, developing talent and building data and analytics capabilities in a growing organization.
- Oncology experience and strong understanding of pharmaceutical disease and customer analytics across development, launch and commercialization.
- Experience developing and scaling new analytical capabilities, including translating business needs into roadmaps, prioritizing investments and driving adoption.
- Experience coordinating global and regional teams with differing capabilities, balancing shared solutions with local needs and influencing without direct authority.
- Expertise in healthcare and commercial data sources, analytical methods, performance measurement and reporting.
- Experience establishing data governance and partnering with technology teams on data integration, analytical platforms and commercial systems.
- Strong business acumen and ability to communicate analytical findings, uncertainty and recommendations clearly to senior leadership and cross-functional partners.
Preferred Skills
- Advanced degree in analytics, data science, statistics, information systems or business.
- Experience launching targeted oncology therapies globally and building capabilities across markets with different data availability and operating models.
- Experience applying advanced analytics, AI and automation to pharmaceutical business questions and measuring the value of new capabilities.
Requirements
- Bachelor’s degree in a quantitative, scientific, technology or business discipline
- 15+ years of relevant biotechnology, pharmaceutical or consulting experience
- Experience leading teams and managers, developing talent and building data and analytics capabilities
- Oncology experience and strong understanding of pharmaceutical disease and customer analytics
- Experience developing and scaling new analytical capabilities
- Experience coordinating global and regional teams with differing capabilities
- Expertise in healthcare and commercial data sources, analytical methods, performance measurement and reporting
- Experience establishing data governance and partnering with technology teams on data integration, analytical platforms and commercial systems
- Strong business acumen and ability to communicate analytical findings to senior leadership
Benefits
- Competitive cash compensation
- Equity awards
- Health benefits
- Learning and development opportunities
Company overview
Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies for RAS-addicted cancers. The company is pioneering a new class of therapeutics that target oncogenic RAS mutations, which are among the most common drivers of human cancers. Revolution Medicines employs a unique approach to drug discovery, leveraging deep insights into RAS biology to develop small molecule inhibitors that can address previously undruggable targets. Their pipeline includes multiple clinical-stage candidates designed to inhibit various RAS pathway mutations, with a particular focus on KRAS G12C and other RAS variants. The company's scientific platform combines structural biology, medicinal chemistry, and computational approaches to design highly selective inhibitors. Revolution Medicines aims to transform cancer treatment by developing therapies that can overcome resistance mechanisms and provide durable clinical benefits for patients with RAS-driven malignancies. Their research represents a significant advancement in the field of targeted cancer therapy, addressing one of the most challenging areas in oncology drug development.